
<rdf:RDF xmlns:edm="http://www.europeana.eu/schemas/edm/" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:dcterms="http://purl.org/dc/terms/" xmlns:skos="http://www.w3.org/2004/02/skos/core#" xmlns:ore="http://www.openarchives.org/ore/terms/" xmlns:svcs="http://rdfs.org/sioc/services#" xmlns:doap="http://usefulinc.com/ns/doap#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#">
  
<ore:Aggregation rdf:about="https://phaidra.vetmeduni.ac.at/o:2075/#Aggregation">
  
<edm:aggregatedCHO rdf:resource="https://phaidra.vetmeduni.ac.at/o:2075"></edm:aggregatedCHO>

  
<edm:dataProvider>University of Veterinary Medicine Vienna</edm:dataProvider>

  
<edm:isShownAt rdf:resource="https://phaidra.vetmeduni.ac.at/o:2075"></edm:isShownAt>

  
<edm:isShownBy rdf:resource="https://phaidra.vetmeduni.ac.at/api/object/o:2075/get"></edm:isShownBy>

  
<edm:object rdf:resource="https://phaidra.vetmeduni.ac.at/api/object/o:2075/thumbnail?w=600"></edm:object>

  
<edm:rights rdf:resource="http://creativecommons.org/licenses/by/4.0/"></edm:rights>

  
</ore:Aggregation>

  
<edm:ProvidedCHO rdf:about="https://phaidra.vetmeduni.ac.at/o:2075">
  
<dc:title xml:lang="en">The nature inspired peptide [T20K]-kalata B1 induces anti-tumor effects in anaplastic large cell lymphoma</dc:title>

  
<dc:description xml:lang="en">Ribosomally synthesized and post-translationally modified peptides, such as plant cyclotides, are a diverse group of natural products well known as templates in drug discovery and therapeutic lead development. The cyclotide kalata B1 (kB1) has previously been discovered as immunosuppressive agent on T-lymphocytes, and a synthetic version of this peptide, [T20K]kB1 (T20K), has been effective in reducing clinical symptoms, such as inflammation and demyelination, in a mouse model of multiple sclerosis. Based on its T-cell modulatory impact we studied the effects of T20K and several analogs on the proliferation of anaplastic large cell lymphoma (ALCL), a heterogeneous group of clinically aggressive diseases associated with poor prognosis. T20K, as a prototype drug candidate, induces apoptosis and a proliferation arrest in human lymphoma T-cell lines (SR786, Mac-2a and the Jurkat E6.1) in a concentration dependent fashion, at least partially via increased STAT5 and p53 signaling. In contrary to its effect on IL-2 signaling in lymphocytes, the cytokine levels are not altered in lymphoma cells. In vivo mouse experiments revealed a promising activity of T20K on these cancer cells including decreased tumor weight and increased apoptosis. This study opens novel avenues for developing cyclotide-based drug candidates for therapy of patients with ALCL.</dc:description>

  
<dc:identifier>https://phaidra.vetmeduni.ac.at/o:2075</dc:identifier>

  
<dc:language>en</dc:language>

  
<edm:type>TEXT</edm:type>

  
<dc:type xml:lang="en">article</dc:type>

  
<dc:subject xml:lang="en">Cyclotide Kalata B1; Peripheral T-Cell; Plant Cyclotides; Cycloviolacin O2; Tumor-Suppressor; Viola-Tricolor; Transcriptome; Mechanism; Products; Stat3</dc:subject>

  
<dcterms:issued>2022</dcterms:issued>

  
<dc:date>2022</dc:date>

  
<dc:creator>Lind, Judith (Medical University of Vienna)</dc:creator>

  
<dc:creator>Kollmann, Karoline (University of Veterinary Medicine Vienna)</dc:creator>

  
<dc:creator>Stoiber, Dagmar (Medical University of Vienna / Ludwig Boltzmann Institute for Cancer Research Vienna / Karl Landsteiner University of Health Sciences)</dc:creator>

  
<dc:creator>Gruber, Christian W. (Medical University of Vienna)</dc:creator>

  
<dc:creator>Edtmayer, Sophie (Karl Landsteiner University of Health Sciences)</dc:creator>

  
<dc:creator>Thell, Kathrin (Medical University of Vienna)</dc:creator>

  
<dc:creator>Gattringer, Jasmin (Medical University of Vienna)</dc:creator>

  
<dc:creator>Moll, Herwig P. (Medical University of Vienna)</dc:creator>

  
<dc:creator>Kudweis, Petra (University of Veterinary Medicine Vienna)</dc:creator>

  
<dc:creator>Hellinger, Roland (Medical University of Vienna)</dc:creator>

  
<dc:publisher>Elsevier</dc:publisher>

  
<dcterms:isPartOf></dcterms:isPartOf>

  
</edm:ProvidedCHO>

  
<edm:WebResource rdf:about="https://phaidra.vetmeduni.ac.at/api/object/o:2075/get">
  
</edm:WebResource>

  
</rdf:RDF>


